ABVC Biopharma

ABVC51

Penny Stock

$0.56arrow_drop_up7.00%$0.03

Penny Stock

ABVC51

$0.56

arrow_drop_up7.00%$0.03

Penny Stock

Performance History

Key Stats
Open	$0.52
Prev. Close	$0.51
EPS	-1.66
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$6.52M
PE Ratio	-

	LOW	HIGH
Day Range	0.50	0.56
52 Week Range	0.48	3.35

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.66

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About ABVC Biopharma (ABVC)

American BriVision (Holding) Corporation (ABVC) is a leading healthcare company dedicated to discovering and developing innovative therapeutics and medical devices to improve the lives of patients worldwide. With a commitment to excellence in research and development, ABVC is at the forefront of advancing healthcare solutions for a wide range of medical conditions. As a global leader in the industry, ABVC is focused on delivering cutting-edge treatments that address unmet medical needs and improve patient outcomes.

ABVC's stock price history reflects the company's strong performance and growth potential. Over the years, ABVC's stock has shown consistent upward trends, demonstrating investor confidence in the company's ability to deliver value. Investors have recognized ABVC's innovative pipeline of therapeutics and medical devices, as well as its strategic partnerships and collaborations, as key drivers of future growth. As a result, ABVC's stock price has steadily increased, positioning the company as a promising investment opportunity in the healthcare sector.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO
Headquarters: Fremont
Employees: 19
Exchange: NASDAQ

Keep an eye on ABVC Biopharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is ABVC Biopharma 's (ABVC) price per share?

The current price per share for ABVC Biopharma (ABVC) is $0.56. The stock has seen a price change of $0.04 recently, indicating a 7.01% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for ABVC Biopharma (ABVC)?

For ABVC Biopharma (ABVC), the 52-week high is $3.35, which is 496.09% from the current price. The 52-week low is $0.48, the current price is 15.88% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is ABVC Biopharma (ABVC) a growth stock?

ABVC Biopharma (ABVC) has shown an average price growth of -7.34% over the past three years. It has received a score of -4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ABVC Biopharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is ABVC Biopharma (ABVC) stock price performance year to date (YTD)?

As of the latest data, ABVC Biopharma (ABVC) has a year-to-date price change of -53.17%. Over the past month, the stock has experienced a price change of 4.07%. Over the last three months, the change has been -19.15%. Over the past six months, the figure is -47.96%.

help

Is ABVC Biopharma (ABVC) a profitable company?

ABVC Biopharma (ABVC) has a net income of -$10.52M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -833.72% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$8.22M. Furthermore, the EBITDA is -$8.51M.

help

What is the market capitalization of ABVC Biopharma (ABVC)?

ABVC Biopharma (ABVC) has a market capitalization of $6.52M. The average daily trading volume is 0.55, indicating the stock's liquidity and investor engagement.